CHICAGO, IL USA (UroToday.com) - Presented by Robert B. Montgomery, MD;1 Mario A. Eisenberger, MD;2 Elisabeth I. Heath, MD;3 A. Oliver Sartor, MD;4 Franklin Chu, MD;5 Neal D. Shore, MD;6 William Jeffery Edenfield, MD;7 Alan J. Koletsky, MD;8 David Uri Lipsitz, MD;9 James S. Cochran, MD;10 Luke T. Nordquist, MD;11 Jennifer Roberts;12 and Mary-Ellen Taplin, MD13 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Click HERE to listen to an interview with Robert Bruce Montgomery, MD, one of the authors of the study
1University of Washington, Seattle, WA; 2The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; 3Karmanos Cancer Institute, Wayne State University, Detroit, MI; 4Tulane University, New Orleans, LA; 5San Bernadino Urological Associates, San Bernadino, CA; 6Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC; 7Cancer Centers of the Carolinas, Greenville, SC; 8Center for Hematology-Oncology, Boca Raton, FL; 9Carolina Urology, Concord, NC; 10Urology Clinics of North Texas, Dallas, TX; 11Urology Cancer Center and GU Research Network, LLC, Omaha, NE; 12Tokai Pharmaceuticals, Cambridge, MA; 13Dana–Farber Cancer Institute, Boston, MA